WIJKSTROM JOAKIM (SVP, Chief Marketing Officer) sold 9.1% of their position (11.83K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $74.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2023ACC: 0001209191-23-016463
Officer· SVP, Chief Marketing Officer
Since Aug 2019
-11.83K
Net shares
Net seller
$74.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.72K
Price / share
$6.23
Trade value
$48.12K
% of position
6.0%
3/2/2023
129.37K→121.65K
Common Stock
Direct
Shares
−4.11K
Price / share
$6.32
Trade value
$25.99K
% of position
3.4%
3/3/2023
121.65K→117.54K
Total
Net shares
−11.83K
Net value
-$74.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2023 | S · Sale | −7.72K | $6.23 | $48.12K | 6.0% | 129.37K | 121.65K |
| Common Stock Direct | 3/3/2023 | S · Sale | −4.11K | $6.32 | $25.99K | 3.4% | 121.65K | 117.54K |
| Total | −11.83K | -$74.12K | ||||||
Derivative Transactions0
No derivative transactions reported